StockData
Q/C Technologies, Inc. logo

Q/C Technologies, Inc. (QCLS) stock

QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.31−0.03 (-8.29%)

Close on Nov 18, 2026Market cap $2.51MP/E –Yield –

Q/C Technologies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Q/C Technologies's revenue for the twelve months ending Jun 30, 2020 was $862.02K, down 54.9% year over year. For fiscal 2019 it was $1.58M, down 5.3% from the year before. The highest annual figure on record is $4.43M in fiscal 2014.

Annual revenue

PeriodPeriod endValueChange
FY2019Dec 31, 2019$1.58M-5.3%
FY2018Dec 31, 2018$1.67M-50.4%
FY2017Dec 31, 2017$3.35M+13.3%
FY2016Dec 31, 2016$2.96M+40.0%
FY2015Dec 31, 2015$2.12M-52.2%
FY2014Dec 31, 2014$4.43M+23.7%
FY2013Dec 31, 2013$3.58M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020-$1.89K-100.4%
Q1 FY2020Mar 31, 2020$363.52K-40.6%
Q4 FY2019Dec 31, 2019$79.59K-71.5%
Q3 FY2019Sep 30, 2019$420.81K-24.5%
Q2 FY2019Jun 30, 2019$464.51K-11.8%
Q1 FY2019Mar 31, 2019$612.12K+102.4%
Q4 FY2018Dec 31, 2018$279.41K-74.0%
Q3 FY2018Sep 30, 2018$557.09K-16.5%
Q2 FY2018Jun 30, 2018$526.60K-19.4%
Q1 FY2018Mar 31, 2018$302.48K-50.7%
Q2 FY2017Jun 30, 2017$1.07M+12.2%
Q1 FY2017Mar 31, 2017$667.25K-9.6%
Q4 FY2016Dec 31, 2016$653.20K–
Q3 FY2016Sep 30, 2016$613.20K–
Q2 FY2016Jun 30, 2016$956.49K–
Q1 FY2016Mar 31, 2016$738.02K–

More Q/C Technologies figures

See a number that looks wrong?